SGLT2 Inhibition Induces Cardioprotection by Increasing Parasympathetic Activity

Circ Res. 2024 Dec 17. doi: 10.1161/CIRCRESAHA.124.324708. Online ahead of print.

Authors

Maryna V Basalay^#¹, Alla Korsak^#², Zhenhe He¹, Alexander V Gourine², Sean M Davidson¹, Derek M Yellon¹

Affiliations

¹ The Hatter Cardiovascular Institute, United Kingdom (M.V.B., Z.H., S.M.D., D.M.Y.).
² Department of Neuroscience, Physiology and Pharmacology, Centre for Cardiovascular and Metabolic Neuroscience, University College London, United Kingdom (A.K., A.V.G.).

^# Contributed equally.

PMID: 39690446
DOI: 10.1161/CIRCRESAHA.124.324708

No abstract available

Keywords: glucose; heart failure; sodium-glucose transporter 2; sodium-glucose transporter 2 inhibitors; stroke volume.

Publication types

Letter